IP Library Assignment 030334/0694
Patent Assignment
Reel/Frame 030334/0694

Assignment of Assignor's Interest

Recorded: 2013-05-02 Pages: 5
Assignors
LEWIS, TIMOTHY S.
Executed: 2013-04-12
LAW, CHE-LEUNG
Executed: 2013-04-30
MCEARCHERN, JULIE A.
Executed: 2013-04-13
Assignee
SEATTLE GENETICS, INC.
21823 30TH DRIVE S.E., BOTHELL, WASHINGTON, 98021
Covered Property (1)
Synergistic Effects Between Auristatin-Based Antibody Drug Conjugates and Inhibitors of the PI3K-Akt Mtor Pathway
Patent: 9,272,052 →
Application: 13/879,012 →
Publication: US 2013/0209496
Related Assignments (1)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name Feb 18, 2021
From: SEATTLE GENETICS, INC.
To: SEAGEN INC.
Reel/Frame 055334/0754 →